Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2010 Sep 1;16(17):4446-51.
doi: 10.1158/1078-0432.CCR-10-0663. Epub 2010 Aug 24.

Inconsistent labeling of food effect for oral agents across therapeutic areas: differences between oncology and non-oncology products

Soonmo Peter Kang  1 , Mark J Ratain
Affiliations

Inconsistent labeling of food effect for oral agents across therapeutic areas: differences between oncology and non-oncology products

Soonmo Peter Kang et al. Clin Cancer Res. .

Abstract

Purpose: Several recent oral oncology drugs were labeled for administration in fasted states despite the fact that food increases their bioavailability. Because this was inconsistent with the principles of oral drug delivery, we hypothesized that there were inconsistencies across therapeutic areas.

Experimental design: Oral agents approved by the U.S. Food and Drug Administration from January 2000 to May 2009 were included in our study. Comparison of the food labeling patterns between oncology and non-oncology drugs was made using Fisher's exact test.

Results: Of the 99 drugs evaluated, 34 showed significant food effects on bioavailability. When food markedly enhanced bioavailability, eight out of nine non-oncology drugs were labeled "fed" to take advantage of the food-drug interaction, whereas all oncology drugs (n = 3) were labeled to be administered in "fasted" states (Fisher's exact test, P = 0.01).

Conclusions: Drug labeling patterns with respect to food-drug interactions observed with oncology drugs are in contradiction with fundamental pharmacologic principles, as exemplified in the labeling of non-oncology drugs. .

PubMed Disclaimer

Figures

FIGURE 1
FIGURE 1. Application of marked food effects on labels: Oncology VS Non-oncology
Food recommendations on 18 drugs with marked food effects (AUC ratio ≥1.5 or ≤0.5). Y-axis represents change of AUC from fasted states to fed states. Food recommendations in labels were to be administered with meals (fed), without meals (fasted), or without regards to meals (either). When food recommendation was made either fed or fasted on drugs with marked increase of AUC, oncology drugs were labeled as fed while most non-oncology drugs were labeled fed. (p=0.01, fisher exact test)
FIGURE 2
FIGURE 2. Relationship between food effects on bioavailability and inter-individual variation of drug exposure
Y-axis represents change in coefficient of variance of AUC from fasted to fed states. X-axis represents food effect on mean AUC. Examination of 23 drugs with significant food effects (AUC ratio ≥1.25 or ≤0.8) and available coefficient of variation (CV) data revealed inverse relationship between change in BA and change in IIV of drug exposure from prandial states.
See this image and copyright information in PMC

Comment in

References

    1. Parsad SD, Ratain MJ. BMJ. 7590. Vol. 334. 2007. Feb 24, Prescribing oral chemotherapy; p. 376. - PMC - PubMed
    1. DeMario MD, Ratain MJ. Oral chemotherapy: rationale and future directions. J Clin Oncol. 1998 Jul;16(7):2557–67. - PubMed
    1. Partridge AH, Avorn J, Wang PS, Winer EP. Adherence to therapy with oral antineoplastic agents. J Natl Cancer Inst. 2002 May 1;94(9):652–61. - PubMed
    1. Singh BN, Malhotra BK. Effects of food on the clinical pharmacokinetics of anticancer agents: underlying mechanisms and implications for oral chemotherapy. Clin Pharmacokinet. 2004;43(15):1127–56. - PubMed
    1. Ratain MJ, Cohen EE. The value meal: how to save $1,700 per month or more on lapatinib. J Clin Oncol. 2007 Aug 10;25(23):3397–8. - PubMed

Publication types

Substances